RIGHT OF FIRST NEGOTIATION/REFUSAL AGREEMENTRefusal Agreement • December 10th, 2007 • Nabi Biopharmaceuticals • Biological products, (no disgnostic substances) • New York
THIS RIGHT OF FIRST NEGOTIATION/REFUSAL AGREEMENT (this “Agreement”), is entered into as of December 4, 2007 (the “Effective Date”), between Nabi Biopharmaceuticals, a Delaware corporation (“Nabi”), having its principal place of business at 12276 Wilkins Avenue, Rockville, Maryland 20852 and Biotest Pharmaceuticals Corporation, a Delaware corporation (“Biotest”), having a principal place of business at 5800 Park of Commerce Boulevard, Boca Raton, Florida 33487 (each a “Party”, and collectively the “Parties”).
TRANSITION SERVICES AGREEMENTTransition Services Agreement • December 10th, 2007 • Nabi Biopharmaceuticals • Biological products, (no disgnostic substances) • New York
THIS TRANSITION SERVICES AGREEMENT (this “Agreement”), is entered into as of December 4, 2007 (the “Effective Date”), by and among Nabi Biopharmaceuticals, a Delaware corporation (“Seller”), and Biotest Pharmaceuticals Corporation, a Delaware corporation (“Buyer”, and with Seller, each a “Party”, and collectively, the “Parties”).
December 4, 2007 Biotest Pharmaceuticals Corporation c/o Biotest AG Landsteinerstr. 5 63303 Dreieich Germany Biotest AG Landsteinerstr. 5 63303 Dreieich Germany RE: Letter Agreement Regarding Interim Operations and Regulatory Arrangements Ladies and...Nabi Biopharmaceuticals • December 10th, 2007 • Biological products, (no disgnostic substances)
Reference is made to that certain Asset Purchase Agreement by and among Nabi Biopharmaceuticals (“Nabi”), Biotest Pharmaceuticals Corporation (“Biotest”) and Biotest AG (“Parent”; and together with Nabi and Biotest, the “Parties”), dated as of September 11, 2007, as amended from time to time (the “Purchase Agreement”). Capitalized terms used in this letter agreement that are not defined herein have the meanings assigned to such terms in the Purchase Agreement. The Parties hereby agree as follows:
